| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1466-1474. Prepublished online as a Blood First Edition Paper on May 17, 2007; DOI 10.1182/blood-2007-03-079178.
HEMATOPOIESIS The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo1 The Walter and Eliza Hall Institute of Medical Research, Parkville; 2 Department of Medical Biology, University of Melbourne, Parkville; 3 Zenyth Therapeutics, Richmond, Australia
Suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of granulocyte-colony stimulating factor (G-CSF) signaling in vivo. SOCS proteins regulate cytokine signaling by binding, via their SH2 domains, to activated cytokine receptors or their associated Janus kinases. In addition, they bind to the elongin B/C ubiquitin ligase complex via the SOCS box. To ascertain the contribution of the SOCS box of SOCS3 to in vivo regulation of G-CSF signaling, we generated mice expressing a truncated SOCS3 protein lacking the C-terminal SOCS box (SOCS3
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||